• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童非酒精性脂肪性肝病(NAFLD):1998 - 2020年美国的趋势、死亡率及社会经济差异

Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD): Trends, Mortality, and Socioeconomic Disparities in the U.S., 1998-2020.

作者信息

Wasuwanich Paul, So Joshua M, Sadek Mustafa, Jarasvaraparn Chaowapong, Rajborirug Songyos, Quiros-Tejeira Ruben E, Karnsakul Wikrom

机构信息

Department of Internal Medicine, Naples Comprehensive Health, Naples, FL 34102, USA.

Department of Internal Medicine, University of Florida College of Medicine, Gainesville, FL 32610, USA.

出版信息

Children (Basel). 2025 Jan 8;12(1):71. doi: 10.3390/children12010071.

DOI:10.3390/children12010071
PMID:39857902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11763524/
Abstract

BACKGROUND/OBJECTIVES: We aim to describe the changing inpatient epidemiology of NAFLD in the U.S. and identify major risk factors associated with mortality in the disease among hospitalized pediatric patients.

METHODS

Hospitalization data from the 1998-2020 National Inpatient Sample were utilized. ICD-9 and ICD-10 codes were used to identify pediatric patients (age less than 18 years old) with NAFLD, and risk factors for mortality were analyzed by logistic regression.

RESULTS

We identified 68,869 pediatric hospitalizations involving NAFLD. Among those, 970 (1.4%) died during hospitalization. Hospitalization rates have been rapidly increasing from 1998 to 2020 (incidence rate ratio (IRR): 1.07; 95% CI: 1.06-1.07; < 0.001). There was a significant difference in mortality based on the type of hospital (rural, non-teaching urban, or teaching urban) in pediatric patients with NAFLD ( < 0.05). Coagulopathy was significantly associated with increased odds of mortality, while age ≥ 12 years, diabetes and obesity were associated with decreased odds of mortality ( < 0.05). Sex, race/ethnicity, hepatitis B, hepatitis C, HIV, and IV drug use were not significantly associated with mortality.

CONCLUSIONS

Our study has shown ever increasing hospitalization rates for NAFLD in pediatric populations and well as significant risk factors associated with mortality. Further studies should be performed as more data on this patient population are collected.

摘要

背景/目的:我们旨在描述美国非酒精性脂肪性肝病(NAFLD)住院患者流行病学的变化,并确定住院儿科患者中与该疾病死亡率相关的主要风险因素。

方法

利用1998 - 2020年国家住院患者样本的住院数据。使用国际疾病分类第九版(ICD - 9)和第十版(ICD - 10)编码来识别患有NAFLD的儿科患者(年龄小于18岁),并通过逻辑回归分析死亡率的风险因素。

结果

我们确定了68869例涉及NAFLD的儿科住院病例。其中,970例(1.4%)在住院期间死亡。从1998年到2020年,住院率一直在快速上升(发病率比(IRR):1.07;95%置信区间:1.06 - 1.07;P < 0.001)。患有NAFLD的儿科患者中,根据医院类型(农村、非教学城市或教学城市)的死亡率存在显著差异(P < 0.05)。凝血障碍与死亡率增加的几率显著相关,而年龄≥12岁、糖尿病和肥胖与死亡率降低的几率相关(P < 0.05)。性别、种族/民族、乙型肝炎、丙型肝炎、艾滋病毒和静脉注射吸毒与死亡率无显著关联。

结论

我们的研究表明,儿科人群中NAFLD的住院率不断上升,以及与死亡率相关的显著风险因素。随着收集到更多关于该患者群体的数据,应进行进一步的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbf/11763524/87d8ee813f29/children-12-00071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbf/11763524/c7f6806398ba/children-12-00071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbf/11763524/93e258bbd787/children-12-00071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbf/11763524/87d8ee813f29/children-12-00071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbf/11763524/c7f6806398ba/children-12-00071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbf/11763524/93e258bbd787/children-12-00071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbf/11763524/87d8ee813f29/children-12-00071-g003.jpg

相似文献

1
Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD): Trends, Mortality, and Socioeconomic Disparities in the U.S., 1998-2020.儿童非酒精性脂肪性肝病(NAFLD):1998 - 2020年美国的趋势、死亡率及社会经济差异
Children (Basel). 2025 Jan 8;12(1):71. doi: 10.3390/children12010071.
2
Trends and Disparities in Pediatric Nonalcoholic Fatty Liver Disease-Associated Hospitalizations in the United States.美国儿童非酒精性脂肪性肝病相关住院治疗的趋势和差异。
J Pediatr Gastroenterol Nutr. 2022 Apr 1;74(4):503-509. doi: 10.1097/MPG.0000000000003384. Epub 2022 Jan 18.
3
Disparities in the Prevalence of Hospitalizations and In-Hospital Mortality Due to Acute Myocardial Infarction Among Patients with Non-Alcoholic Fatty Liver Disease: A Nationwide Retrospective Study.非酒精性脂肪性肝病患者急性心肌梗死住院率和院内死亡率的差异:一项全国性回顾性研究
J Clin Med. 2024 Nov 18;13(22):6946. doi: 10.3390/jcm13226946.
4
Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer - nationwide population-based study.遗传性血色素沉着症:时间趋势、社会人口学特征及肝细胞癌的独立危险因素——基于全国人群的研究
World J Hepatol. 2022 Sep 27;14(9):1804-1816. doi: 10.4254/wjh.v14.i9.1804.
5
Peptic ulcer disease in non-alcoholic fatty liver disease hospitalizations: A new challenge on the horizon in the United States.非酒精性脂肪性肝病住院患者中的消化性溃疡病:美国即将面临的新挑战。
World J Hepatol. 2023 Apr 27;15(4):564-576. doi: 10.4254/wjh.v15.i4.564.
6
Sex and racial disparities in non-alcoholic fatty liver disease-related cardiovascular events: National inpatient sample analysis (2019).非酒精性脂肪性肝病相关心血管事件中的性别和种族差异:全国住院患者样本分析(2019年)
World J Cardiol. 2024 Mar 26;16(3):137-148. doi: 10.4330/wjc.v16.i3.137.
7
Alcohol-associated Cirrhosis and Alcoholic Hepatitis Hospitalization Trends in the United States.美国与酒精相关的肝硬化和酒精性肝炎住院治疗趋势。
J Clin Gastroenterol. 2021 Feb 1;55(2):174-179. doi: 10.1097/MCG.0000000000001378.
8
Increasing Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease Among Hospitalized Adults in the United States.美国住院成年人群中非酒精性脂肪性肝病的临床和经济负担日益加重。
J Clin Gastroenterol. 2019 Nov/Dec;53(10):765-771. doi: 10.1097/MCG.0000000000001229.
9
PM air pollution exposure and nonalcoholic fatty liver disease in the Nationwide Inpatient Sample.大气细颗粒物污染暴露与全国住院患者样本中的非酒精性脂肪肝
Environ Res. 2022 Oct;213:113611. doi: 10.1016/j.envres.2022.113611. Epub 2022 Jun 7.
10
Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.非酒精性脂肪性肝病患者住院与全因死亡率增加相关,与心血管危险因素无关。
PLoS One. 2020 Oct 27;15(10):e0241357. doi: 10.1371/journal.pone.0241357. eCollection 2020.

引用本文的文献

1
The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity.甘油三酯-葡萄糖(TyG)指数及改良TyG指数预测肥胖儿童人群中代谢相关脂肪性肝病和代谢综合征的能力
J Clin Med. 2025 Mar 28;14(7):2341. doi: 10.3390/jcm14072341.

本文引用的文献

1
Risk factors of nonalcoholic fatty liver disease in healthy women.健康女性非酒精性脂肪性肝病的危险因素。
Medicine (Baltimore). 2023 Aug 4;102(31):e34437. doi: 10.1097/MD.0000000000034437.
2
AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新:非侵入性生物标志物在非酒精性脂肪性肝病评估和管理中的作用:专家综述。
Gastroenterology. 2023 Oct;165(4):1080-1088. doi: 10.1053/j.gastro.2023.06.013. Epub 2023 Aug 4.
3
Family-centered interventions for children and adolescents with type 1 diabetes mellitus: an integrative review.
针对1型糖尿病儿童和青少年的以家庭为中心的干预措施:一项综合综述。
Child Health Nurs Res. 2023 Jan;29(1):7-23. doi: 10.4094/chnr.2023.29.1.7. Epub 2023 Jan 31.
4
The additive effect of genetic and metabolic factors in the pathogenesis of nonalcoholic fatty liver disease.遗传和代谢因素在非酒精性脂肪性肝病发病机制中的相加作用。
Sci Rep. 2022 Oct 20;12(1):17608. doi: 10.1038/s41598-022-22729-5.
5
Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives.非酒精性脂肪性肝病相关肝细胞癌的风险因素和诊断生物标志物:当前证据和未来展望。
World J Gastroenterol. 2022 Jul 21;28(27):3410-3421. doi: 10.3748/wjg.v28.i27.3410.
6
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring.非酒精性脂肪性肝病及其遗传、表观遗传和环境因素对子代的影响。
World J Gastroenterol. 2022 Jul 7;28(25):2890-2899. doi: 10.3748/wjg.v28.i25.2890.
7
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).美国临床内分泌学会临床实践指南:原发性保健和内分泌学临床环境中非酒精性脂肪性肝病的诊断和管理:由美国肝病研究协会(AASLD)共同赞助。
Endocr Pract. 2022 May;28(5):528-562. doi: 10.1016/j.eprac.2022.03.010.
8
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications.非酒精性脂肪性肝病相关的凝血与内皮功能障碍:现状与治疗意义
J Clin Transl Hepatol. 2022 Apr 28;10(2):339-355. doi: 10.14218/JCTH.2021.00268. Epub 2022 Jan 12.
9
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors.非酒精性脂肪性肝病与心血管疾病:共同的心血管代谢危险因素综述。
Hypertension. 2022 Jul;79(7):1319-1326. doi: 10.1161/HYPERTENSIONAHA.122.17982. Epub 2022 Apr 25.
10
Trends and Disparities in Pediatric Nonalcoholic Fatty Liver Disease-Associated Hospitalizations in the United States.美国儿童非酒精性脂肪性肝病相关住院治疗的趋势和差异。
J Pediatr Gastroenterol Nutr. 2022 Apr 1;74(4):503-509. doi: 10.1097/MPG.0000000000003384. Epub 2022 Jan 18.